US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine.
In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Companion Diagnostics Market
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs. ┬áIt also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
Natural and Organic Foods and Beverages in the U.S., 4th Edition
7/16/2014 | published by: Packaged Facts
... years earlier, with the organic foods sector leaping ahead 12.5% in 2014. Amid this rapid growth, the marketplace is changing rapidly, with new plays by traditional retailers like Kroger, Walmart, and Target, and strengthening competition ...  |  read more...
USD 3,995
Medical and Scientific Research, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
... and ARM LIMITED. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research Global analysis is perfect for investors to: See the market leaders ...  |  read more...
USD 1,425
Medical and Scientific Research in Europe
8/12/2014 | published by: Plimsoll Publishing Ltd.
... NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO and CBMM EUROPE B.V.. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research European analysis is perfect ...  |  read more...
USD 1,200
Physician Views: How do oncologists expect use of Kyprolis will be affected by Amgen's positive ASPIRE data?
8/14/2014 | published by: FirstWord
... myeloma patients, thus greatly multiplying the drug's commercial potential. In the three quarters since the deal closed, investors have put up with relatively unremarkable sales growth for Kyprolis but have been getting antsy waiting for ...  |  read more...
USD 645
Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
8/14/2014 | published by: MarketsandMarkets
... exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems as well as the low cost of conducting exome sequencing, as compared with that ...  |  read more...
USD 4,650
Biotechnology, Nordic Region
8/12/2014 | published by: Plimsoll Publishing Ltd.
... English language) includes a wealth of information on the financial trends over the past four years. latest Biotechnology Nordic analysis is perfect for investors to: See the market leaders Identify companies heading for failure Seek ...  |  read more...
USD 1,050
Proteomics, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
... includes a wealth of information on the financial trends over the past four years. latest Proteomics Global analysis is perfect for investors to: See the market leaders Identify companies heading for failure Seek out the ...  |  read more...
USD 1,425
Metabolon, Inc. - Product Pipeline Analysis, 2014 Update
8/13/2014 | published by: GlobalData
... Metabolon's Quantose IR test is a blood test performed for detecting early-stage insulin resistance; and Prostarix and Prostarix Plus tests are urine-based tests used in the detection of prostate cancer risk. The company partners with ...  |  read more...
USD 750
Biotechnology in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... activities such as dna, contract pharmaceutical drug development services, biotechnology, microbiology, hygiene and includes a wealth of information on the financial trends over the past four years. latest Biotechnology analysis is perfect for investors to: ...  |  read more...
USD 525
Analytical Instrumentation and Systems in the United Kingdom
8/12/2014 | published by: Plimsoll Publishing Ltd.
... and MARKES INTERNATIONAL LTD. Covering activities such as control, systems, vacuum, surface analysis, x-span and includes a wealth of information on the financial trends over the past four years. latest Analytical Instrumentation & Systems analysis ...  |  read more...
USD 525
Drug Discovery Technologies - A Global Market Overview
8/28/2014 | published by: Industry Experts
... in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has ...  |  read more...
USD 3,060
G-Protein Coupled Receptor (GPCR) Targeting -Technologies and Global Markets
8/1/2014 | published by: BCC Research
... blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes ...  |  read more...
USD 6,650
WaferGen Bio:systems, Inc : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' AMYRIS, Inc. (formerly Amyris Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Cell Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer CropScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Bayer MaterialScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Galapagos NV : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Generex Biotechnology Corporation : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
InterMune, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Intercell AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Intercell AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10